These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30456697)

  • 1. Neuroendocrine Liver Metastasis-a Specific Set of Markers to Detect Primary Tumor Sites.
    Selberherr A; Koperek O; Riss P; Scheuba C; Kaderli R; Perren A; Niederle B
    Endocr Pathol; 2019 Mar; 30(1):31-34. PubMed ID: 30456697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
    Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
    Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.
    Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CDX2 and Thyroid Transcription Factor-1 in Oropharyngeal Undifferentiated Carcinomas: A Potential Diagnostic Pitfall.
    Chernock RD; Bibbey S; El-Mofty SK; Carpenter DH; Lewis JS
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):268-273. PubMed ID: 27389559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin.
    Koo J; Mertens RB; Mirocha JM; Wang HL; Dhall D
    Mod Pathol; 2012 Jun; 25(6):893-901. PubMed ID: 22388755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
    Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
    Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.
    Yang Z; Klimstra DS; Hruban RH; Tang LH
    Am J Surg Pathol; 2017 Jul; 41(7):915-922. PubMed ID: 28498280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver.
    Denby KS; Briones AJ; Bourne PA; Spaulding BO; Lu D; Fischer-Colbrie R; Qu Z; Wang HL; Xu H
    Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):573-9. PubMed ID: 22495359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids.
    Saqi A; Alexis D; Remotti F; Bhagat G
    Am J Clin Pathol; 2005 Mar; 123(3):394-404. PubMed ID: 15716236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.
    Hermann G; Konukiewitz B; Schmitt A; Perren A; Klöppel G
    Virchows Arch; 2011 Aug; 459(2):147-54. PubMed ID: 21739268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
    Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
    Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet-1 is a sensitive but not entirely specific marker for pancreatic neuroendocrine neoplasms and their metastases.
    Graham RP; Shrestha B; Caron BL; Smyrk TC; Grogg KL; Lloyd RV; Zhang L
    Am J Surg Pathol; 2013 Mar; 37(3):399-405. PubMed ID: 23348208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
    Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
    Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdx2 as a marker for neuroendocrine tumors of unknown primary sites.
    Erickson LA; Papouchado B; Dimashkieh H; Zhang S; Nakamura N; Lloyd RV
    Endocr Pathol; 2004; 15(3):247-52. PubMed ID: 15640551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
    Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
    Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas.
    Lee H; Fu Z; Koo BH; Sheehan CE; Young GQ; Lin J; Patil DT; Yang Z
    Ann Diagn Pathol; 2018 Dec; 37():30-34. PubMed ID: 30236546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 1 associated with a new mutation in the menin gene and a midgut neuroendocrine tumor.
    Agarwal R; Szalkiewicz ER; Warner RR; Roayaie S; Hechtman JF; Zhu H; Kim MK
    Pancreas; 2014 Jan; 43(1):145-6. PubMed ID: 24326372
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin.
    Juhlin CC; Zedenius J; Höög A
    Endocr Pathol; 2020 Dec; 31(4):401-410. PubMed ID: 32813226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
    Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
    Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary.
    Dabir PD; Svanholm H; Christiansen JJ
    APMIS; 2018 Jun; 126(6):494-500. PubMed ID: 29924451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.